共 50 条
[45]
Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects
[J].
Inflammopharmacology,
2023, 31
:2445-2449